BioRestorative Therapies (BRTX) Accumulated Expenses (2010 - 2026)
BioRestorative Therapies' Accumulated Expenses was $744,485 in Q4 2024, up 4.6% from $711,686 a year earlier and up 9.1% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Accumulated Expenses (2010 - 2026) Analysis & Trends
From Q4 2010 onward, BioRestorative Therapies has reported Accumulated Expenses for 55 quarters.
- Accumulated Expenses shows a five-year compound annual growth rate of -27.1% (FY2019 to FY2024).
- In earlier years, Accumulated Expenses was $711,686 in FY2023 (+447.1%), $130,072 in FY2022 (-3.6%), $134,970 in FY2021 (-82.4%) and $767,566 in FY2020 (-78.8%).
- The Q4 2024 figure marks the highest quarterly Accumulated Expenses since Q2 2021.
- Compared with a year earlier, Accumulated Expenses has increased for eight straight quarters, with growth averaging 150.3% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2023 (growth of 447.1%); the worst was Q2 2020 (a decline of 98.4%).
- Per Business Quant data, BRTX's Accumulated Expenses in the three quarters before Q4 2024 was $682,237 (Q3 2024), $447,622 (Q2 2024) and $338,343 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 947,739.00 |
| Dec 31, 2025 | 982,047.00 |
| Sep 30, 2025 | 607,470.00 |
| Jun 30, 2025 | 480,925.00 |
| Mar 31, 2025 | 277,610.00 |
| Dec 31, 2024 | 744,485.00 |
| Sep 30, 2024 | 682,237.00 |
| Jun 30, 2024 | 447,622.00 |
| Mar 31, 2024 | 338,343.00 |
| Dec 31, 2023 | 711,686.00 |
| Sep 30, 2023 | 548,954.00 |
| Jun 30, 2023 | 386,325.00 |
| Mar 31, 2023 | 232,984.00 |
| Dec 31, 2022 | 130,072.00 |
| Sep 30, 2022 | 114,647.00 |
| Jun 30, 2022 | 114,659.00 |
| Mar 31, 2022 | 156,037.00 |
| Dec 31, 2021 | 134,970.00 |
| Sep 30, 2021 | 590,356.00 |
| Jun 30, 2021 | 1.09 Mn |
API Access
BioRestorative Therapies Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();